Analysis of characteristics of paratyphoid A in 157 Chinese inpatients between 1998 and 2009.
The objectives of this study were to understand the epidemic rules, clinical characteristics, and drug resistance of paratyphoid A by analyzing 157 cases in the Wenzhou area of China during a 12-year period. The subjects included in the present study were patients with paratyphoid A who were admitted to the First Affiliated Hospital of Wenzhou Medical College (Wenzhou, ZJ, China) between 1998 and 2009. The disease mainly occurred in persons aged 20 to 50 years. The peak incidence was between 2001 and 2003 (n = 85). Paratyphoid A was more likely to occur in winter and spring in this area. In many cases (33.8%), the condition was complicated by underlying diseases. The length of hospital stay was relatively long, averaging 17.68 days. The white blood cell (WBC) count was 2-8 × 10(9)/L in 88.5% of cases. Eosinophils disappeared in 51.7% of cases. The erythrocyte sedimentation rate (ESR) was not significant and lower than 60 mm/h in 88.5% of cases. Alanine aminotransferase (ALT) was ≤3-fold greater than the normal value in 84.3% of cases. The Widal test was positive in only 7.7% of our cases. The sensitivity of many antibiotics was over 90%. Paratyphoid A in the Wenzhou area has unique epidemic rules, clinical characteristics, and drug resistance. The results of our retrospective analysis are instructive for the early diagnosis and rational treatment of paratyphoid A.
Yu
F
F
Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China. tjyufujun@163.com
Fan
S
S
Fan
X
X
Dong
P
P
Wang
X
X
Chen
Y
Y
Li
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002681:China / Q000453:epidemiology; D005260:Female; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D007902:Length of Stay; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010284:Paratyphoid Fever / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology* / Q000473:pathology; D012189:Retrospective Studies; D012482:Salmonella paratyphi A / Q000302:isolation & purification*; D055815:Young Adult
D000900:Anti-Bacterial Agents
Indian J Pediatr. 2008 May;75(5):509-10
18537014
Trop Doct. 2010 Jul;40(3):160-2
20478986
Hum Vaccin. 2009 Jun;5(6):420-4
19276655
Diagn Microbiol Infect Dis. 2009 Aug;64(4):422-6
19631095
Indian Pediatr. 2007 Dec;44(12):939
18175854
Bull World Health Organ. 2004 May;82(5):346-53
15298225
JAMA. 2009 Aug 26;302(8):859-65
19706859
J Clin Microbiol. 2001 Mar;39(3):1002-7
11230418
Heart Lung. 2004 Nov-Dec;33(6):414-6
15597296
Indian J Med Microbiol. 2010 Jan-Mar;28(1):51-3
20061765
Scand J Infect Dis. 2005;37(4):309-10
15804669
Med Mal Infect. 2008 Dec;38(12):667-70
18951744
Arch Pathol Lab Med. 2006 Jun;130(6):767-78
16740026
Trop Doct. 2009 Oct;39(4):223-4
19762576
BMC Public Health. 2009 Dec 20;9:476
20021691
Emerg Infect Dis. 2005 Nov;11(11):1764-6
16318734
Int J Antimicrob Agents. 2010 Aug;36(2):155-8
20478696
J Travel Med. 2008 Sep-Oct;15(5):366-8
19006514
J Infect Dev Ctries. 2008 Dec 01;2(6):475-8
19745527
Indian J Med Sci. 2004 Apr;58(4):161-2
15122052
Trans R Soc Trop Med Hyg. 2007 Oct;101(10):1032-8
17673269
Nihon Rinsho. 2005 Jul;63 Suppl 7:142-5
16111211
BMC Public Health. 2009 Apr 27;9:115
19397806
Diagn Microbiol Infect Dis. 2010 Feb;66(2):207-9
19800753
Indian J Pathol Microbiol. 2009 Oct-Dec;52(4):505-8
19805957